SARS-CoV-2-IN-35 structure
|
Common Name | SARS-CoV-2-IN-35 | ||
---|---|---|---|---|
CAS Number | 2757763-47-4 | Molecular Weight | 621.67 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C29H34F3N5O5S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of SARS-CoV-2-IN-35SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 can be used in research of COVID-19[1]. |
Name | SARS-CoV-2-IN-35 |
---|
Description | SARS-CoV-2-IN-35 is a potent and orally active SARS-CoV-2 M pro inhibitor with a Ki value of 12.1 nM. SARS-CoV-2-IN-35 can be used in research of COVID-19[1]. |
---|---|
Related Catalog | |
In Vivo | SARS-CoV-2-IN-35 (compound 5; 10 mg/kg; p.o.) has good oral utilization in Wistar-Han rats[1]. Animal Model: Wistar-Han rats[1] Dosage: 10 mg/kg Administration: Oral administration Result: Had oral F of 33 %. |
References |
Molecular Formula | C29H34F3N5O5S |
---|---|
Molecular Weight | 621.67 |